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Abstract
Purpose: In assessing the severity of age-related macular degeneration (AMD), the Age-Related Eye
Disease Study (AREDS) Simplified Severity Scale predicts the risk of progression to late AMD. However, its
manual use requires the time-consuming participation of expert practitioners. Although several automated
deep learning systems have been developed for classifying color fundus photographs (CFP) of individual
eyes by AREDS severity score, none to date has used a patient-based scoring system that uses images from
both eyes to assign a severity score.
Design: DeepSeeNet, a deep learning model, was developed to classify patients automatically by the
AREDS Simplified Severity Scale (score 0-5) using bilateral CFP.
Participants: DeepSeeNet was trained on 58,402 and tested on 900 images from the longitudinal
follow-up of 4,549 participants from AREDS. Gold standard labels were obtained using reading center
grades.
Methods: DeepSeeNet simulates the human grading process by first detecting individual AMD risk
factors (drusen size, pigmentary abnormalities) for each eye and then calculating a patient-based AMD
severity score using the AREDS Simplified Severity Scale.
Main OutcomeMeasures: Overall accuracy, specificity, sensitivity, Cohen’s kappa, and area under the
curve (AUC). The performance of DeepSeeNet was compared with that of retinal specialists.
Results: DeepSeeNet performed better on patient-based classification (accuracy = 0.671; kappa =
0.558) than retinal specialists (accuracy = 0.599; kappa = 0.467) with high AUC in the detection of large
drusen (0.94), pigmentary abnormalities (0.93), and late AMD (0.97). DeepSeeNet also outperformed retinal
specialists in the detection of large drusen (accuracy 0.742 vs. 0.696; kappa 0.601 vs. 0.517) and pigmen-
tary abnormalities (accuracy 0.890 vs. 0.813; kappa 0.723 vs. 0.535) but showed lower performance in the
detection of late AMD (accuracy 0.967 vs. 0.973; kappa 0.663 vs. 0.754).
Conclusions: By simulating the human grading process, DeepSeeNet demonstrated high accuracy with
increased transparency in the automated assignment of individual patients to AMD risk categories based on
the AREDS Simplified Severity Scale. These results highlight the potential of deep learning to assist and
enhance clinical decision-making in patients with AMD, such as early AMD detection and risk prediction
for developing late AMD. DeepSeeNet is publicly available on https://github.com/ncbi-nlp/
DeepSeeNet.
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Age-related macular degeneration (AMD) is responsible for approximately 9% of global blindness and
is the leading cause of visual loss in developed countries.1, 2 The number of people with AMD worldwide
is projected to be 196 million in 2020, increasing substantially to 288 million in 2040.3 The prevalence
of AMD increases exponentially with age: late AMD in white populations has been estimated by meta-
analysis at 6% at 80 years and 20% at 90 years.4 Over time, increased disease prevalence through changing
population demographics may place great burdens on eye services, especially where retinal specialists are
not available in sufficient numbers to perform individual examinations on all patients. It is conceivable that
deep learning or telemedicine approaches might support future eye services; however, this might only apply
when evidence-based systems have undergone extensive validation and demonstrated performance metrics
that are at least noninferior to those of clinical ophthalmologists in routine practice.
Age-related macular degeneration arises from a complex interplay among aging, genetics, and environ-
mental risk factors.5, 6 It is regarded as a progressive, stepwise disease and is classified by clinical features
(based on clinical examination or color fundus photography) into early, intermediate, and late stages.7 The
hallmarks of intermediate disease are the presence of large drusen or pigmentary abnormalities at the mac-
ula. There are 2 forms of late AMD: (1) neovascular AMD and (2) atrophic AMD, with geographic atrophy
(GA).
The Age-Related Eye Disease Study (AREDS), sponsored by the National Eye Institute (National Insti-
tutes of Health), was a randomized clinical trial to assess the effects of oral supplementation with antioxidant
vitamins and minerals on the clinical course of AMD and age-related cataract. Longitudinal analysis of this
study cohort led to the development of the patient-based AREDS Simplified Severity Scale for AMD, based
on color fundus photographs.8 This simplified scale provides convenient risk factors for the development of
advanced AMD that can be determined by clinical examination or by less demanding photographic proce-
dures than used in the AREDS. The scale combines risk factors from both eyes to generate an overall score
for the individual, based on the presence of 1 or more large drusen (diameter > 125µm) or AMD pigmentary
abnormalities at the macula of each eye.8 The Simplified Severity Scale is also clinically useful in that it
allows ophthalmologists to predict an individual’s 5-year risk of developing late AMD. This 5-step scale
(from score 0 to 4) estimates the 5-year risk of the development of late AMD in at least 1 eye as 0.4%, 3.1%,
11.8%, 25.9%, and 47.3%, respectively.8
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Automated image analysis tools have demonstrated promising results in biology and medicine.9–15 In
particular, deep learning, a subfield of machine learning, has recently generated substantial interest in the
field of ophthalmology.9, 16–21 Past studies have used deep learning systems for the identification of var-
ious retinal diseases, including diabetic retinopathy,22–27 glaucoma,27–30 retinopathy of prematurity,31 and
AMD.19, 21, 27, 32, 33 In general, deep learning is the process of training algorithmic models with labeled data
(e.g., color fundus photographs categorized manually as containing pigmentary abnormalities or not), where
these models can then be used to assign labels automatically to new data. Deep learning differs from tradi-
tional machine learning methods in that specific image features do not need to be prespecified by experts in
that field. Instead, the image features are learned directly from the images themselves.
Recently, several deep learning systems have been developed for the classification of color fundus
photographs into AMD severity scales, at the level of the individual eye. These severity scales have included
both binary (e.g., referable vs. nonreferable AMD17, 19, 21, 27, 32) and multi-class (e.g., the 9-step AREDS
Severity Scale16, 34 and a 4-class AMD classification35) systems. However, to the best of our knowledge,
none to date has developed a patientbased system that, similar to the AREDS Simplified Severity Scale
score, uses images from both eyes to obtain one overall score for the individual. This is particularly relevant
because estimates of rates of progression to late AMD are highly influenced by the status of fellow eyes,
because the behavior of the 2 eyes is highly correlated.8 Additionally, several recent studies have reported
robust performance in the automated classification of AMD from OCT scans.21, 36–39 Unlike these studies,
DeepSeeNet is based on data from color fundus photography, which remains an important imaging modality
for assessing the ophthalmic disease and is essential in grading eyes using the AREDS Simplified Severity
Score.40 Similar to the study by De Fauw et al,37 DeepSeeNet contains 2 stages by design for improved
performance and increased transparency. However, their 2-stage approach is different from ours with respect
to the actual approach details as well as issues in data variability.
The primary aim of our study was to train and test a deep learning model to identify patient-level AMD
severity using the AREDS Simplified Severity Scale from color fundus images of both eyes. Images were ob-
tained from the AREDS dataset, one of the largest available datasets containing approximately 60,000 retinal
images. Different from previous methods, our model mimics the human grading process by first detecting
individual risk factors (drusen and pigmentary abnormalities) in each eye and then combining values from
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both eyes to assign an AMD score for the patient. Thus, our model closely matches the clinical decision-
making process, which allows an ophthalmologist to inspect and visualize an interpretable result, rather than
being presented with an AMD score by a “black-box” approach. This approach offers potential insights
into the decision-making process, in a fashion more typical of clinical practice, and has the advantages of
transparency and explainability.
Methods and Materials
The specific aims of the study were (1) to compare the performance of 3 deep learning models generated by 3
different training strategies; and (2) for the most accurate of these 3 models, to compare its performance with
that of retinal specialists (AREDS investigators whose assessments had previously been recorded during the
AREDS).
The reference measure used as the “gold standard” for both training purposes and the measurement of
performance was the grading previously assigned to each color fundus photograph by human graders at the
Reading Center for the AREDS, as described next.
Assignment of the AREDS Simplified Severity Scale by Reading Center grading
This study used the AREDS dataset.8 Briefly, the AREDS was a 12-year multi-center, prospective cohort
study of the clinical course, prognosis, and risk factors of AMD and age-related cataract. Institutional review
board approvals were obtained from all 11 clinical sites, and written informed consents were obtained from
all AREDS participants. Stereoscopic color fundus photographs from both eyes (field 2, 30° imaging field
centered at the fovea) were obtained at the study baseline, the 2-year followup visit, and annually thereafter.
Because of the inherent redundancy in a pair of stereoscopic photographs, for each eye, only 1 of the pair
of photographs was used in the current study. In general, the left image of the pair was used unless missing
from the database, in which case the right image was used instead (∼ 0.5%).
The gold standard annotation (image labeling) was performed by expert human graders at the Reading
Center (University of Wisconsin). The workflow is described in detail in AREDS Report number 6.41 In
brief, a senior grader (grader 1) performed preliminary grading of the photograph for AMD severity using a
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standardized protocol for a 4-category scale, and a junior grader (grader 2) performed detailed grading of the
photograph for multiple specific AMD features. A computerized algorithm then extracted the AMD severity
levels from the detailed gradings (by grader 2). In the case of any discrepancy regarding the AMD severity
level between the graders, a senior investigator would adjudicate the final severity level. All photographs
were graded independently, that is, graders were masked to the photographs and grades from previous visits.
Senior graders had approximately 10 to 15 years of experience, and junior graders had up to 5 years of
experience.
In addition, a rigorous process of grading quality control was performed at the Reading Center including
the assessment for the inter-grader and intra-grader agreement overall and according to specific AMD fea-
tures.41 Analyses for potential “temporal drift” were conducted by having all graders re-grade in a masked
fashion the same group of images annually for the duration of the study.
For each participant, at each time point, grades for both eyes were used to calculate the AREDS Simpli-
fied Severity Scale score. This scale ranges from 0 to 5, with a score of 0 to 4 assigned to participants based
on the drusen/pigment status in each eye, and a score of 5 assigned to participants with late AMD (defined
as neovascular AMD or central GA) in either eye (Fig. 1). This is a modification of the original scoring
method described by Ferris et al.8 As described previously, these scores were used as gold standard labels
(i.e., reference), both for training purposes and to assess the performance of the different models developed
in this study.
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Figure 1: Scoring schematic for participants with and without late agerelated macular degeneration (AMD).
Pigmentary abnormalities: 0 = no, 1 = yes; drusen size: 0 = small or none, 1 = medium, 2 = large; late AMD:
0 = no, 1 = yes.
Image datasets used in the training and testing of the deep learning model
The AREDS dataset is publicly accessible to researchers by request at dbGAP (https://www.ncbi.
nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000001.v3.p1).8 A
total of 59,302 color fundus images from 4,549 participants were extracted from the AREDS dataset. This
dataset was divided into 2 subsets: (1) a testing dataset, which consisted of bilateral images captured at the
study baseline from 450 participants (i.e., 1 image from each eye); at the time of the study, in addition to un-
dergoing normal Reading Center grading, these images were also assessed (separately and independently) by
the retinal specialists, whose responses were recorded; and (2) a training dataset, which consisted of 58,402
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images from the remaining 4,099 participants, captured at multiple study visits (although not all participants
had follow-up visits through to 12 years). The images taken from the group of 450 participants at visits
other than the baseline visit were not used in either dataset (Fig. S1). Table 1 summarizes the distribution
of participants by the AREDS Simplified Severity Scale at baseline. Table 2 summarizes the distributions of
scored AMD features among the training and testing datasets.
Table 1: Summary of Age-Related Eye Disease Study Participants Accord-
ing to Age-Related Eye Disease Study Simplified Severity Scale Scores at
Study Baseline (by Reading Center Grading)
AREDS Simplified No. of Participants (% Total)
Severity Scale Score Training Testing
0 1,258 (30.7) 185 (41.1)
1 653 (15.9) 79 (17.6)
2 461 (11.3) 56 (12.4)
3 303 (7.4) 46 (10.2)
4 279 (6.8) 33 (7.3)
5 537 (13.1) 51 (11.3)
Total participants 4,099 (100.0) 450 (100.0)
AREDS = Age-Related Eye Disease Study.
Table 2: Number of Color Fundus Images in the Training and Testing Sets Stratified
by Risk Factors and Late Age-related Macular Degeneration Categorization
Risk factors
Number of Fundus Images (% Total)
Training (all visits) Testing (baseline)
Drusen
Small/none 23,625 (40.5) 395 (43.9)
Medium 16,020 (27.4) 206 (22.9)
Large 18,757 (32.1) 299 (33.2)
Pigmentary abnormalities
No 36,712 (62.9) 631 (70.1)
Yes 21,690 (37.1) 269 (29.9)
Late AMD
No 50,800 (87.0) 849 (94.3)
Yes 7,602 (13.0) 51 (5.7)
Total images 58,402 (100.0) 900 (100.0)
AMD = age-related macular degeneration.
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Composition of the DeepSeeNet deep learning model
DeepSeeNet was designed as a deep learning model that could be used to assign patient-based AREDS
Simplified Severity Scale scores in an automated manner using bilateral color fundus photographs (Fig. S2).
DeepSeeNet simulates the grading process of ophthalmologists by first detecting the presence or absence
of AMD risk-associated features for each eye (large drusen and AMD pigmentary abnormalities) and then
using these bilateral data to compute a patient-based score (0-5) using the algorithm described earlier.
DeepSeeNet consists of 3 constituent parts that contribute to its output: (a) a sub-network, Drusen-
Net (D-Net), which detects drusen in 3 size categories (small/none, medium, and large); (b) a sub-network,
Pigment-Net (P-Net), which detects the presence or absence of pigmentary abnormalities (hypopigmentation
or hyperpigmentation); and (c) a sub-network, Late AMD-Net (LA-Net), which detects the presence or
absence of late AMD (neovascular AMD or central GA).
D-Net, P-Net, and LA-Net were designed as deep convolutional neural networks (CNNs),42 each with
an Inception-v3 architecture,43 which is a state-of-the-art CNN model for image classification. In total, there
are 317 layers in the Inception-v3 model, comprising a total of > 21 million weights (learnable parameters)
that were subject to training.
Before training, we followed the lead of Burlina et al18, 35 to preprocess our image data as follows:
the AREDS fundus photographs were cropped to generate a square image field encompassing the macula,
followed by scaling the image to a resolution of 224×224 pixels (Fig. S3). We trained our model in Keras
with TensorFlow as the backend.44, 45 During the training process, we updated the model parameters using
the Adam optimizer (learning rate of 0.0001) for every minibatch of 32 images.46 This reduces the variance
of the parameter update, which leads to a more stable convergence. The training was stopped after 5 epochs
(passes of the entire training set) once the accuracy values no longer increased or started to decrease. All
experiments were conducted on a server with 32 Intel Xeon CPUs, using a NVIDIA GeForce GTX 1080 Ti
11Gb GPU for training and testing, with 512 Gb available in RAM memory.
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Performance comparison between DeepSeeNet and retinal specialists
We compared the performance of the deep learning model with that of retinal specialists, using the Reading
Center grades as the gold standard, in both cases. For the performance of the retinal specialists, we used the
AREDS Simplified Severity Scale scores that had previously been recorded from the retinal specialists who
originally served as the AREDS investigators. These scores were recorded at the AREDS baseline study
visits, when the retinal specialists (n = 88) had independently assessed 450 AREDS participants as part
of a qualification survey used to determine initial AMD severity for each eye. The clinical assessment in-
volved the determination of the following features: drusen size (within 2 disc diameter of the macula center),
presence of pigmentary abnormalities consistent with AMD (within 1 disc diameter), AMD subretinal neo-
vascularization, previous laser photocoagulation for AMD subretinal neovascularization, central GA, retinal
pigment epithelial detachment, and disciform scar. These clinical assessments were used to derive the same
patient-based Simplified Severity Scale as defined in Fig. 1.
Overall accuracy, specificity, sensitivity, Cohen’s kappa,47, 48 and receiver operating characteristic curve
analysis were used to evaluate the performance of DeepSeeNet and retinal specialists (with reference to the
Reading Center grades as the gold standard). Kappa values < 0 indicate no agreement, 0 to 0.20 indicate
slight agreement, 0.21 to 0.40 indicate fair agreement, 0.41 to 0.60 indicate moderate agreement, 0.61 to
0.80 indicate substantial agreement, and 0.81 to 1 indicate almost perfect agreement.49 We also followed the
work of Poplin et al50 to assess the statistical significance of the results. For the test dataset, we sampled 450
patients with replacement and evaluated the model on this sample. By repeating this sampling and evaluation
2,000 times, we obtained a distribution of the performance metric (e.g., kappa) and reported 95% confidence
intervals.
Results
Predicting AREDS simplified severity scale
DeepSeeNet predicted AREDS Simplified Severity Scale scores for each participant in the testing dataset
(n = 450). The performance of the deep learning models was measured against the Reading Center grades
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previously assigned to these 450 participants (as the reference or gold standard).
We investigated 3 strategies for training and optimizing DeepSeeNet (details located under “Training
Strategies” in the in Appendix 1, Fig. S4, and Table S3) and found the fine-tuning strategy (all layers in
a pretrained Inception-v3 model were fine-tuned using the AREDS dataset) achieved the best results, with
accuracy = 0.671 and kappa = 0.558. As a result, we will discuss only Fine-tuned DeepSeeNet hereafter.
The performance of Fine-tuned DeepSeeNet was then compared with that of the retinal specialists
(Table 3). The performance of DeepSeeNet (accuracy = 0.671; kappa = 0.558) was superior to that of the
retinal specialists (accuracy = 0.599; kappa = 0.467).
Table 3: Performance of Fine-tuned DeepSeeNet Compared with
Retinal Specialists on Classifying Age-Related Eye Disease Study
Simplified Severity Scale Scores from Color Fundus Photographs
Fine-tuned DeepSeeNet Retinal specialist
(95% CI) (95% CI)
Overall accuracy 0.671 (0.670-0.672) 0.599 (0.598-0.600)
Sensitivity 0.590 (0.589-0.591) 0.512 (0.511-0.513)
Specificity 0.930 (0.930-0.930) 0.916 (0.916-0.916)
Kappa 0.558 (0.557-0.560) 0.467 (0.466-0.468)
CI = confidence interval.
In addition, the performance of the individual sub-networks used in Fine-tuned DeepSeeNet (D-Net,
P-Net, and LA-Net) was compared with that of retinal specialists (Table 4). Fig. 2 displays receiver operator
characteristic curves for the individual sub-networks, with the average performance of the retinal specialists
shown as single red points. The performance of D-Net and P-net was superior to the performance of the
retinal specialists in assessing large drusen and pigmentary abnormalities, respectively. The accuracy of LA-
Net was similar to that of the retinal specialists in assessing the presence of late AMD, but its kappa was
lower.
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Table 4: Performance of Risk Factor Prediction (Retinal Specialists vs. Individual Sub-Network Models)
Drusen Pigmentary Changes Late AMD
Retinal specialist D-Net Retinal specialist P-Net Retinal specialist LA-Net
Overall accuracy (95% CI) 0.696 (0.695-0.697) 0.742 (0.741-0.742) 0.813 (0.813-0.814) 0.890 (0.889-0.890) 0.973 (0.973-0.973) 0.967 (0.967-0.967)
Sensitivity (95% CI) 0.635 (0.634-0.636) 0.718 (0.717-0.719) 0.615 (0.613-0.616) 0.732 (0.731-0.733) 0.801 (0.798-0.805) 0.627 (0.626-0.632)
Specificity (95% CI) 0.842 (0.842-0.843) 0.871 (0.871-0.872) 0.898 (0.898-0.899) 0.957 (0.957-0.957) 0.983 (0.983-0.984) 0.987 (0.987-0.987)
Kappa (95% CI) 0.517 (0.516-0.518) 0.601 (0.600-0.602) 0.535 (0.533-0.536) 0.723 (0.722-0.724) 0.754 (0.751-0.757) 0.663 (0.660-0.665)
AMD = age-related macular degeneration; CI = confidence interval; D-Net = Drusen-Net, which classifies drusen into 3 size categories (small/none, medium, and
large); LA-Net = Late AMD-Net, which detects the presence or absence of late AMD (neovascular AMD or central geographic atrophy [GA]); P-Net = Pigment-Net,
which detects the presence or absence of any pigmentary abnormality consistent with AMD (hypopigmentation or hyperpigmentation).
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Figure 2: Receiver operating characteristic curves for large drusen, pigmentary abnormalities, and late age-
related macular degeneration (AMD) classification. Retinal specialists’ performance levels are represented
as a single red point. AUC = area under the curve.
Fig. 3 shows confusion matrices comparing the performance of Fine-tuned DeepSeeNet and the retinal
specialists in grading AMD severity (with accuracy comparisons detailed in Table S1). These matrices depict
the true versus the predicted AREDS Simplified Severity Scale scores of the 450 participants at baseline. The
numbers of predictions are summarized with count values broken down by each class, indicating the accuracy
and errors made by DeepSeeNet or the retinal specialists. Fig. 3 shows that DeepSeeNet correctly classified
scores 0 to 4 more often than the retinal specialists, whereas the retinal specialists correctly classified late
AMD more often than DeepSeeNet.
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Figure 3: Confusion matrices comparing retinal specialists’ performance with that of DeepSeeNet based on
the test set values. The rows and columns of each matrix are the Scale scores (0-5).
Last, the performance of Fine-tuned DeepSeeNet on all images in the test set (accuracy = 0.662; kappa
= 0.555) was compared with that on the images at study baseline only (Table S2 and Table S3). We observed
that the accuracy on the study baseline was slightly better, though the kappas values were similar. Although
the distribution of AMD severity (for the testing cases) was slightly less severe for the study baseline images,
we do not consider this to have introduced bias because the test cases were the same for the model as for the
retinal specialists.
Interpretation
Although Fine-tuned DeepSeeNet demonstrated relatively robust performance on classifying color fundus
photographs according to AMD severity, the mechanics of this and other deep learning models are some-
times considered cryptic or lacking in transparency. Indeed, for this reason, deep learning models are often
referred to as “black-box” entities. To improve transparency, in addition to creating models composed of
sub-networks with overt purposes, we applied 2 additional techniques to aid interpretation of the results.
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T-Distributed Stochastic Neighbor Embedding (t-SNE) Method
In this study, the internal features learned by Fine-tuned DeepSeeNet were studied using t-distributed
Stochastic Neighbor Embedding (see Glossary in Table 5), which is well suited for the visualization of
high-dimensional datasets.51 We first obtained the 128-dimensional vector of DeepSeeNet’s last dense layer
and applied the t-distributed Stochastic Neighbor Embedding technique to reduce the vector into 2 dimen-
sions for visualization (Fig. 4). Fig. 4 demonstrates that, for drusen, small/none drusen and large drusen
were split across the medium drusen point cloud. The figure contains some points that are clustered with the
wrong class, many of which are medium drusen and difficult to identify. For pigmentary abnormality and
late AMD, presence and absence classes were separated clearly.
Figure 4: The t-distributed Stochastic Neighbor Embedding (t-SNE) visualization of the last hidden layer
representation for each sub-network of Deep- SeeNet. Each point represents a fundus image. Different colors
represent the different classes of the respective risk factor or late age-related macular degeneration (AMD).
Saliency Method
The second method used to aid interpretation of the results toward model transparency was the saliency
method. To visualize important areas in the color fundus images (i.e., those areas that contributed most to-
ward classification), we applied image-specific class saliency maps to assess manually whether DeepSeeNet
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was concentrating on image areas that human experts would consider the most appropriate to predict AMD
severity.51 The saliency map is widely used to represent the visually dominant location in a given image,
corresponding to the category of interest, by back-projecting the relevant features through the CNN. It helps
highlight areas used by the deep learning algorithm for prediction and can provide insight into misclassified
images. For example, as seen in the “drusen” category of Fig. 5, the areas highlighted in the saliency maps
are indeed areas with drusen that are visually apparent in the color fundus images. Likewise, in the “pigmen-
tary changes” and “late AMD” categories in Fig. 5, the areas highlighted in the saliency maps are visually
confirmed to correspond with the relevant features in the corresponding color fundus images. However, al-
though saliency maps aid interpretation by highlighting the dominant areas, they are limited in that they do
not completely explain how the algorithm came to its final decision.
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Drusen
Pigmentary changes
Late AMD
Fundus image Saliency map Fundus image Saliency map
Figure 5: Image-specific class saliency maps applied to 6 color fundus photographs: 2 eyes with large drusen,
2 eyes with pigmentary abnormalities, and 2 eyes with late age-related macular degeneration (AMD). In
the saliency maps, the areas marked with bright signal correspond to the pixels that contributed most to the
model’s classification of that class. The corresponding color fundus photograph is shown next to the saliency
map for reference.
Discussion
The accuracy of Fine-Tuned DeepSeeNet was superior to that of human retinal specialists (accuracy 67%
vs. 60%), together with moderate agreement with the ground truth as indicated by the kappa score. If deep
learning approaches were to support eye services in the future, comparisons of this kind (with demonstration
of noninferiority to human clinicians) would be very important, together with extensive validation across
multiple and diverse image datasets. Of note, although the overall accuracy of Fine-tuned DeepSeeNet was
superior, subgroup analysis showed that Fine-tuned DeepSeeNet classified participants with Severity Scale
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scores 0 to 4 correctly more often than the retinal specialists, whereas the retinal specialists classified late
AMD correctly more often than Fine-Tuned DeepSeeNet (Fig. 3). However, one important potential reason
for the latter difference is that the number of images of late AMD that were available for model training
was relatively low at 13.0% of the total training set (537 participants). We postulate that further training of
Fine-tuned DeepSeeNet with larger numbers of late AMD images may improve its performance in this area.
Error analysis on misclassified images in the AREDS testing dataset
We considered that useful lessons might be learned by careful examination of those instances where Fine-
tuned DeepSeeNet made errors in the Severity Scale classification, particularly (as described earlier) in the
case of late AMD (where its accuracy was lower than that of the retinal specialists). The matrices shown in
Fig. 3 demonstrate that, for actual Severity Scale scores of 0 to 4, in the large majority of cases, the score
predicted by Fine-tuned DeepSeeNet was incorrect by 1 scale step only. We also examined those cases in
which Fine-tuned DeepSeeNet incorrectly classified a participant as having late AMD (score 5) and found
that, in 50% of these cases, noncentral GA was present in at least 1 eye. For the purposes of this study,
noncentral GA was not defined as late AMD, although recent studies have expanded the definition of late
AMD to include noncentral GA.7 The misclassification of these images by our deep learning model suggests
an inherent similarity between these groups of images.
Image quality also affected the accuracy of the deep learning model. Of the participants classified
incorrectly by Fine-tuned DeepSeeNet as having late AMD, 25.0% had digital artifacts obscuring the fovea.
In addition, image brightness affected the model accuracy. Participants with a pale retina or digital artifacts
were more likely to be misclassified as having GA. In the future, we aim to address these problems by
identifying color fundus photographs with inferior quality, either for exclusion or for additional processing.
Strengths, limitations, and future work
One current limitation of DeepSeeNet (at least in its present iteration) arises from the imbalance of cases
that were available in the AREDS dataset used for its training, particularly the relatively low proportion of
participants with late AMD. As described previously, this is likely to have contributed to the relatively lower
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accuracy of DeepSeeNet in the classification of late AMD, that is, through the performance of LA-Net in
the overall model. However, this limitation may potentially be addressed by further training using image
datasets with a higher proportion of late AMD cases.
A limitation of this dataset includes the sole use of color fundus photographs because these were the
only images obtained in a study that began in 1992. Other imaging techniques such as OCT and fundus
autofluorescence images were not yet feasible or universally available. Future studies would benefit from
inclusion of additional methods of imaging. Multimodal imaging would be desirable.
Another potential limitation lies in the reliance of DeepSeeNet on higher levels of image quality for
accurate classification. Unlike in other studies,16, 19 we did not perform extensive preprocessing of images,
such as the detection of the outer boundaries of the retina or normalization of the color balance and local
illumination. It is possible that the use of these techniques might have improved the accuracy of the model.
However, we deliberately avoided extensive preprocessing to make our model as generalizable as possible.
We recommend further testing of our deep learning model using other datasets of color fundus images.
In addition, it would be interesting for future studies to compare the accuracy of the model with that of
different groups of ophthalmologists (e.g., retinal specialists, general ophthalmologists, and trainee ophthal-
mologists). Indeed, a recent study on grader variability for diabetic retinopathy severity using color fundus
photographs suggested that retinal specialists have a higher accuracy than that of general ophthalmologists.52
In this study, we set the bar as high as possible for the deep learning model, because we considered that the
retinal specialists might have accuracy as close as possible to that of the Reading Center gradings.
In conclusion, this study shows that DeepSeeNet performed patient-based AMD severity classification
with a level of accuracy higher than a group of human retinal specialists. If these results are tested and
validated by further reports of superiority across multiple datasets (ideally from different countries), it is
possible that the integration of deep learning models into clinical practice might become increasingly ac-
ceptable to patients and ophthalmologists. In the future, deep learning models might support eye services
by reducing the time and human expertise needed to classify retinal images and might lend themselves well
(through telemedicine approaches) to improving care in geographical areas where current services are absent
or limited. Although deep learning models are often considered “black-box” entities (because of difficul-
ties in understanding how algorithms make their predictions), we aimed to improve the transparency of
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DeepSeeNet by constructing it from sub-networks with clear purposes (e.g., drusen detection) and analyzing
its outputs with saliency maps. These efforts to demystify deep learning models may help improve levels
of acceptability to patients and adoption by ophthalmologists. We have also analyzed the performance of
several distinct training strategies; lessons from these approaches may have applicability to the development
of deep learning models for other retinal diseases, such as diabetic retinopathy, and even for image-based
deep learning systems outside of ophthalmology.
Our new model uses deep learning in combination with a clinically useful, patient-based, AMD classi-
fication system that combines risk factors from both eyes to obtain a score for the patient. The deep learning
model and data partition are publicly available (https://github.com/ncbi-nlp/DeepSeeNet).
By making these available, we aim to maximize the transparency and reproducibility of this study, and to
provide a benchmark method for the further refinement and development of methodologies. In addition,
this deep learning model, trained on one of the largest publicly available color fundus photograph reposito-
ries, may allow for future deep learning studies of other retinal diseases in which only smaller datasets are
currently available.
In the future, we aim to improve the model by incorporating other information such as demographic,
medical, and genetic data, potentially together with imaging data from other modalities. We also plan to
evaluate our model on a new dataset from the second AREDS (AREDS2) sponsored by the National Eye
Institute. In addition, we hope to investigate the combination of OCT-based and color fundus photographs-
based deep learning models once each has been more highly validated individually. Taken together, we
expect this study will contribute to the advancement and understanding of retinal disease and may ultimately
enhance clinical decision-making.
Glossary
Term Description
Adam optimizer Adam is an optimization algorithm to update network weights. Different from
classic optimization that maintains a single learning rate for all weight updates,
with the learning rate not changing during training, it computes adaptive learning
rates for different parameters during the training.46
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Back-propagation A method used in artificial neural networks to calculate a gradient that is needed
in the calculation of the weights to be used in the network.53
Convolutional neural
network
A class of artificial neural network algorithms utilized in deep learning largely for
image classification.
Deep learning A subfield of machine learning in which explicit features are determined from the
training data and do not require pre-specification by human domain experts.
Epoch A single pass through the entire training set.
Fine-tune A process to take a neural network model that has already been trained for a given
task, and make it perform a second task.
Fully-connected
layer
A linear operation in which every output neuron has connections to all activations
in the previous layer.
Hidden layer The middle layer of a neural network.
ImageNet An image database comprised of > 14 million natural images and their corre-
sponding labels. Due to the large number of labeled images, this dataset is often
employed in deep learning techniques to pre-train models. In a process known
as “transfer learning”, the first layers are trained with ImageNet to extract more
primitive features from the images (e.g., edge detection).
Inception-v3 A convolutional neural network with the inception architecture for computer vi-
sion.43
Layer A container that usually receives weighted input, transforms it with a set of mostly
non-linear functions, and then passes these values as output to the next layer.
Leaning rate A hyper-parameter that controls how much the weights of deep neural network
are adjusted with respect the loss gradient.
Multiclass classifica-
tion
A classification task with more than two classes.
Multilayer percep-
tron
A class of feedforward artificial neural network that consists of at least one hidden
layer.
Over-fitting The production of an analysis that corresponds too closely or exactly to a par-
ticular set of data and may therefore fail to fit additional data or predict future
observations reliably.
Saliency map The saliency map is computed for an input image and a given output class. It tells
us which pixels in the image contribute most to the model’s classification of that
class. Specifically, we first computed the gradient of a given label with respect
to the input image. The gradient, by definition, points in the direction of the
greatest rate of class changes with respect to a small change in the input images.
That small region of changes in the input image, thereby, contributes most and is
highlighted in the saliency map.
Stochastic gradient
descent
An iterative method for optimizing the objective function in machine learning.
Test set A mutually exclusive set of images not utilized in the training set. These images
are used for testing deep learning models to evaluate their performance levels.
Training A data-driven approach requiring tens of thousands of labeled images in the train-
ing set.
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Training set The set of images used for training a deep learning model. The network then
predicts the category of each image and compares it with known “ground truth”
labels. The parameters in the network are then optimized to improve the model’s
predictive ability, in a process known as “back-propagation”.
Transfer learning The process of training a deep learning model on a large set of data, such that
the model’s weights are optimized as learned features. These weights are then
“transferred” to a new neural network to allow for more efficient training of the
model on a new training set (often smaller in size).
t-distributed Stochas-
tic Neighbor Embed-
ding
A technique used to visualize and explore complex datasets (particularly those
with high-dimensional features) in a low-dimensional space. In our case, we used
it to create a 2-dimensional map by assigning a location to each datapoint (each
retinal image). The locations are decided by probability distributions, such that
datapoints that are similar across high-dimensional features end up close to each
other, and datapoints that are dissimilar end up far apart. As a result, t-SNE plots
often seem to display clusters (e.g., the cluster for large drusen, in this case),
where the datapoints in the cluster all have relatively similar features. Therefore,
it can be used to help the classification process and in the visual inspection and
exploration of results from deep learning experiments.54
Weights Learnable parameters of the deep learning model.
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Appendix 1
Training strategies
Three training strategies were investigated for model training (Figure S4). (1) We created a ‘Multi-layer per-
ceptron’ (‘MLP’) model by taking an pre-trained Inception-v3 model on ImageNet55 (an image database of
> 14 million natural images with corresponding labels; see Glossary), then training it on the AREDS dataset
as a multi-layer perceptron model (with two densely-connected layers of 256 and 128 units, respectively).
In this model, the AREDS images were used to train only the last two layers of the entire model. (2) We
created the ‘Fine-tuned DeepSeeNet’ model by taking an pre-trained Inception-v3 model on ImageNet (i.e.,
same process and same weights as for the MLP model), then training it on the AREDS images. However, for
this model, the training process on the AREDS images was used to fine-tune all layers (not just the last two
layers). Hence, ultimately, the entire model is trained using the AREDS dataset. (3) Lastly, we created the
‘Fully-trained DeepSeeNet’ model. In this case, we proceeded directly from an Inception-v3 model (with
randomly-initialized weights) to training (all layers) using the AREDS images. Hence, in this model, the
ImageNet dataset was not utilized for pre-training. More information on the training methodologies can
be found in the Supplementary material. The three training strategies were assessed in turn on the testing
dataset: Fine-tuned DeepSeeNet, Fully-trained DeepSeeNet, and MLP. The performance of the three training
models is shown in Table S3. Of the three, the model with the best performance was Fine-tuned DeepSeeNet
(i.e., where the model was pre-trained using ImageNet, and all layers were fine-tuned using the AREDS
training dataset), with accuracy=0.671 and kappa=0.558.
First, Fine-tuned DeepSeeNet performed more accurately than Fully-trained DeepSeeNet. Fully-trained
DeepSeeNet was trained using the same AREDS images, but (unlike Fine-tuned DeepSeeNet) was not pre-
trained using the ImageNet images. Hence, Fine-Tuned DeepSeeNet had the advantage of pre-initialized
weights. The superior accuracy of this training approach suggests that, although it is possible to train a deep
learning model from scratch by using a large new dataset, it is still beneficial in practice to initialize with
weights from a pre-trained model (particularly when we consider that there are over 14 million images in
ImageNet, compared to 60,000 in the AREDS training set). One possible reason for the inferior accuracy
of the model fully trained using the AREDS images is over-fitting, i.e., the model starts to memorize rather
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than learn to generalize from the training data. A negative consequence is, therefore, that the model has poor
performance on the validation dataset.56, 57
Fine-tuned DeepSeeNet also performed more accurately than the MLP deep learning model. Both deep
learning models were pre-trained using the ImageNet images and then trained using the AREDS fundus
images. However, the training of Fine-tuned DeepSeeNet was designed specifically to tackle AMD classifi-
cation: during training using the AREDS images, the weights of all its layers were permitted to change. By
contrast, the MLP model underwent training using the same AREDS images, but only as a fixed feature ex-
tractor, i.e., the weights of all but two of its layers were not permitted to change. For Fine-tuned DeepSeeNet,
we permitted all layers to be retrained using the AREDS dataset, as we considered that the AREDS dataset
of images was sufficiently large, with features different from the ImageNet images, to justify optimization
of all layers.
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Figure S1. AREDS training and testing sets for classification of patient-based age-related macular degeneration severity from color 
fundus photographs.Figure S1: AREDS training and testing sets for classification of patient-based age-related macular degener-
ation severity from color fundus photographs.
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Figure S2. Workflow of DeepSeeNet.Figure S2: Workflow of DeepSeeNet.
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Figure S3. Images before and after preprocessing.
Figure S3: Images before and after preprocessing.
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Figure S4: Different deep learning algorithmic training strategies: fine-tuning, Inception-v3 as fixed feature
extractor, and full-training.
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Table S1: Accuracy comparing retinal specialists’ performance with that of Fine-tuned DeepSeeNet based
on the test set values.
Class Instance Retinal specialist Fine-tuned DeepSeeNet
0 185 83.8% 90.8% 7.0
1 79 29.1% 43.0% 13.9
2 56 39.3% 48.2% 8.9
3 46 26.1% 34.8% 8.7
4 33 45.5% 72.7% 27.2
5 51 82.4% 64.7% -17.7
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Table S2: Performance of DeepSeeNet on assessing AREDS Simplified Severity
Scale scores from images at the study baseline and overall data.
Study baseline Overall
(95% CI) (95% CI)
Overall accuracy 0.671 (0.670-0.672) 0.662 (0.662-0.623)
Sensitivity 0.590 (0.589-0.591) 0.592 (0.591-0.593)
Specificity 0.930 (0.930-0.930) 0.928 (0.928-0.928)
Kappa 0.558 (0.557-0.560) 0.555 (0.554-0.557)
CI = confidence interval.
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Table S3: Performance of three different deep learning models (generated by three different training strate-
gies); on classifying AREDS Simplified Severity Scale scores from color fundus photographs.
MLP Fine-tuned DeepSeeNet Fully-trained DeepSeeNet
(95% CI) (95% CI) (95% CI)
Overall accuracy 0.436 (0.435-0.437) 0.671 (0.670-0.672) 0.624 (0.623-0.625)
Sensitivity 0.236 (0.235-0.236) 0.590 (0.589-0.591) 0.494 (0.493-0.495)
Specificity 0.862 (0.862-0.862) 0.930 (0.930-0.930) 0.919 (0.918-0.919)
Kappa 0.163 (0.162-0.164) 0.558 (0.557-0.560) 0.487 (0.486-0.488)
MLP = multilayer perceptron; CI = confidence interval.
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